Regional distribution and kinetics of [18F]6-flurodopamine as a measure of cardiac sympathetic activity in humans

Heart

Volumn 75, Issue 1, 1996, Pages 29-34

  Coates, Geoffrey ^a,b   Chirakal, Raman ^a   Fallen, Ernest L ^a   Firnau, Günter ^a   Garnett, E Stephen ^a   Kamath, Markad V ^a   Scheffel, Anita ^a   Nahmias, Claude ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

Cardiac sympathetic system; Dopamine labelled with fluorine 18; Noradrenaline; Regional distribution and kinetics of 18f 6 fluorodopamine in myocardium

Indexed keywords

DOPAMINE; FLUORINE 18; GLYCERYL TRINITRATE; NORADRENALIN;

ADRENERGIC SYSTEM; ARTICLE; CONTROLLED STUDY; HEART DISEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SUBLINGUAL DRUG ADMINISTRATION; TISSUE DISTRIBUTION;

ADULT; DOPAMINE; EXERCISE; FLUORINE RADIOISOTOPES; HEART; HEART TRANSPLANTATION; HUMANS; MIDDLE AGED; MYOCARDIUM; NITROGLYCERIN; NOREPINEPHRINE; SYMPATHETIC NERVOUS SYSTEM;

EID: 0030024465     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.75.1.29     Document Type: Article

References (32)

1. Meredith IT, Broughton A, Jennings GL, Esler MD. Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. N Engl J Med 1991;325:618-24.
2. Brush JE Jr, Eisenhofer G, Garty M, Stull R, Maron BJ, Cannon RO, et al. Cardiac norepinephrine kinetics in hypertrophic cardiomyopathy. Circulation 1989;79: 836-44.
3. Goldstein DS, Chang PC, Eisenhofer G, Miletich R, Finn R, Bacher J, et al. Positron emission tomographic imaging of cardiac sympathetic innervation and function. Circulation 1990;81:1606-21.
4. 18F]6-fluorodopamine: initial findings in humans. J Am Coll Cardiol 1993;22:1961-71.
5. 18F]6-fluorodopamine. Proceedings of the 9th International Symposium on Radiopharmaceutical Chemistry. J Label Comp Radiopharm 1992;32:275-9.
6. 18F]-6-fluorodopamine. J Nucl Med 1991; 32:102-10.
7. Horwitz LD, Gorlin R, Taylor WJ, Kemp HG. Effects of nitroglycerine on regional myocardial blood flow in coronary artery disease. J Clin Invest 1971;50: 1578-84.
8. Fallen EL, Kamath MV, Ghista DN. Power spectrum of heart rate variability: a non-invasive test of integrated neurocardiac function. Clin Invest Med 1988;11: 331-40.
9. Kamath MV, Fallen EL, McKelvie R. Effects of steady state exercise on the power spectrum of heart rate variability. Med Sci Sports Exerc 1991;23(4):428-34.
10. Press WH, Flanner BP, Teukolsky SA, Vetterling WT. Numerical recipes: the art of scientific computing. New York: Cambridge University Press, 1986.
11. 18F] fluorodopamine in baboons: heart uptake, metabolism and the effect of desipramine. J Nucl Med 1993;34: 619-29.
12. Chiueh CC, Zukowska-Grojec Z, Kirk KL, Kopin IJ. Fluorocatecholamines as false adrenergic neurotransmitters. J Pharmacol Exp Ther 1983;225:529-33.
13. Eisenhofer G, Hovevey-Sion D, Kopin IJ, Miletich R, Kirk KL, Finn R. Neuronal uptake and metabolism of 2- and 6-fluorodopamine: false neurotransmitters for positron emission tomographic imaging of sympathetically innervated tissues. J Pharmacol Exp Ther 1989;248: 419-27.
14. Chang PC, Szermeredi K, Grossman E, Kopin IJ, Goldstein DS. Fate of tritiated 6-fluorodopamine in rats: a false neurotransmitter for positron emission tomographic imaging of sympathetic innervation and function. J Pharmacol Exp Ther 1990;225:809-17.
15. Yamaguchi N, de Champlain J, Nadeau R. Correlation between the response of the heart to sympathetic stimulation and the release of endogenous catecholamines into the coronary sinus of the dog. Circ Res 1975;36: 662-8.
16. Honda T, Ninomiya I, Azumi T. Cardiac sympathetic nerve activity and catecholamine kinetic in cat hearts. Am J Physiol 1989;252:H879-85.
17. Dela F, Mikines KJ, Von Linstow M, Galbo H. Heart rate and plasma catecholamines during 24 hrs of everyday life in trained and untrained men. J Appl Physiol 1992;73(6):2389-95.
18. Schwaiger M, Hutchins GD, Kalff V, Rosenspire K, Haka MS, Mallette S, et al. Evidence for regional catecholamine uptake and storage sites in the transplanted human heart by positron emission tomography. J Clin Invest 1991;87:1681-90.
19. Fallen EL, Kamath MV, Chista DN, Fitchett D. Spectral analysis of heart rate variability following human heart transplantation. J Auton Nerve Syst 1988;23: 199-206.
20. Schwaiger M, Kalff V, Rosenspire K, Haka MS, Molina E, Hutchins GD, et al. Noninvasive evaluation of sympathetic nervous system in human heart by positron emission tomography. Circulation 1990;82: 457-64.
21. DeGrado TR, Hutchins GD, Toorongian SA, Wieland DM, Schwaiger M. Myocardial kinetics of carbon-11-meta-hydroxyephedrine: retention mechanisms and effects of norepinephrine. J Nucl Med 1993;34: 1287-93.
22. Sisson JC, Wieland DM, Sherman P, Manger TJ, Tobes MC, Jacques S, et al. Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function. J Nucl Med 1987;28:1620-4.
23. 123I metaidobenzyguanidine. J Nucle Med 1981;22:129-32.
24. Dae MW, O'Connell JW, Botvinick EH, Ahearn T, Yee E, Huberty JP, et al. Scintigraphic assessment of regional cardiac adrenergic innervation. Circulation 1989;79: 634-44.
25. Merlet P, Valette H, Dubois-Randé J-L, Moyse D, Dove P, Bourguignon MH, et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 1992;33:471-7.
26. Wakasugi S, Wada A, Hasegawa Y, Nakano S, Shibata N. Detection of abnormal cardiac adrenergic neuron activity in adriamycin-induced cardiomyopathy with iodine-123-metaiodobenzylguanidine. J Nucl Med 1992;33: 208-14.
27. 124I-meta-iodobenzlguanidine (MIBG) uptake in hypertrophic cardiomyopathy. Am Heart J 1990;119:1329-37.
28. Stanton MS, Tuli MM, Radtke NL, Heger JJ, Miles WM, Mock BH, et al. Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using I-123-metaiodobenzylguanidine. J Am Coll Cardiol 1989;14:1519-26.
29. Dae MW, De Marco T, Botvinick EH, O'Connell JW, Hattner RS, Huberty HP, et al. Scintigraphic assessment of MIBG uptake in globally denervated human and canine hearts - implications for clinical studies. J Nucl Med 1992;33:1444-50.
30. 3H-dopamine in isolated perfused rat heart. Br J Pharmacol 1971,41:256-69.
31. 21C CGP-12177 to assess β-adrenergic receptor concentration in idiopathic dilated cardiomyopathy. Circulation 1993;87:1169-78.
32. Delforge J, Syrota A, Lançon J-P, Nakajima K, Loc'h C, Janier M, et al. Cardiac beta-adrenergic receptor density measured in vivo using PET, CGP 12177, and a new graphical method. J Nucl Med 1991;32:739-48.